• Rapid Diagnosis of Community Acquired Pneumonia

Laboratory Products

Rapid Diagnosis of Community Acquired Pneumonia

Jan 29 2008

Across Europe and the US, Community Acquired Pneumonia (CAP) affects 100 per 100,000 adults a year with a mortality rate of 10-20%, say the WHO.
Inverness Medical Professional Diagnostics has responded to the need to rapidly and accurately diagnose CAP by introducing BinaxNOW® S. pneumoniae and Legionella, part of the BinaxNOW® range of rapid respiratory tests. The simple, swab based BinaxNOW S. pneumoniae and Legionella immunochromatographic assays provide clear reliable results in as little as 15 minutes from urine samples.

Through BinaxNOW’s ability to test and provide patients with their results in one visit, healthcare professionals can ensure the most appropriate treatment is administered without delay and that hospitalisation and potentially life threatening complications are avoided.

The BinaxNOW range of rapid tests for respiratory infections covers Influenza A and B, Legionella, RSV, Strep A and S. pneumoniae. With an easy to use patented book-shaped test device, Inverness Medical continues to enable early and accurate diagnosis of disease with its BinaxNOW rapid tests.

Digital Edition

Lab Asia 29.6 Dec

December 2022

In This Edition Chromatography - Optimising Viral Vector Purification Strategies with Multimodal Chromatography - Key UHPLC Characteristics Required for High throughput LC-MS - New Low Volu...

View all digital editions


Arab Health

Jan 30 2023 Dubai, UAE

Nano Tech 2023

Feb 01 2023 Tokyo, Japan

Medlab Middle East

Feb 06 2023 Dubai, UAE


Feb 14 2023 Cologne, Germany

View all events